Dow Up 0.26% Nasdaq Down 1.07%

Alexza Pharmaceuticals Inc. (ALXA)

-NasdaqGM
2.72 Down 0.27(9.03%) 3:59PM EDT
Prev Close:2.99
Open:2.96
Bid:0.27 x 1000
Ask:3.15 x 400
1y Target Est:9.50
Beta:1.92
Earnings Date:Nov 4 - Nov 10 (Est.)
Day's Range:2.65 - 2.96
52wk Range:2.53 - 5.93
Volume:298,075
Avg Vol (3m):152,430
Market Cap:47.25M
P/E (ttm):N/A
EPS (ttm):-1.74
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for ALXA

Comparison

Symbol% ChgMkt Cap
ALXADown 9.03%47.25M
ALKSDown 1.51%6.37B
ARDMDown 4.55%148.21M
LLYDown 0.12%69.86B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):7.29
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-2.29
Quarterly EPS Est (Sep-14) :-0.77
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Alexza Pharmaceuticals, Inc., a pharmaceutical company, focuses on the research, development, and commercialization of novel proprietary products for the acute treatment of central nervous system conditions worldwide. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback